Vidence, LLC

Vidence, LLC is a healthcare research services company committed to providing comprehensive analytic services and real-world insights into community oncology practice and patient outcomes. The company's proprietary technology platform, SCIMON, leverages clinical, genomic, and patient-reported data to generate real-world evidence on clinical, humanistic, and economic outcomes, with a focus on expanding oncology treatment options and improving the patient experience. The platform includes a wealth of critical data elements such as electronic health records (EHR), genomic testing data, details on medication, surgery and radiation treatment, and patient-reported outcomes. Founded in 2019 and headquartered in the United States, with records dating back to 2012, SCIMON contains data on over 125,000 adult oncology lives, across all tumor types. With the potential to revolutionize how real-world evidence is harnessed to enhance oncology treatment, Vidence, LLC presents an intriguing opportunity for venture capital investment within the healthcare industry.